Reading Time: 2 minutesIntroduction Cirrhosis, a progressive liver disease, poses significant challenges to medical professionals and patients alike. In the United States, it predominantly affects males, often stemming from chronic alcohol abuse, viral hepatitis, or non-alcoholic fatty liver disease. Serostim, a recombinant human growth hormone, has been explored as a potential therapeutic agent in managing cirrhosis. This article delves into a comprehensive analysis of Serostim therapy's effects on liver function in American males with cirrhosis, focusing on liver enzymes and patient outcomes over a decade. Liver Enzyme Profiles and Serostim Therapy Liver enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl … Continue reading
-
Injectable Sermorelin

-
Search -
Archives
- May 2025
- April 2025
- March 2025
- February 2025
- April 2024
- March 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- February 2019
- January 2019
-
HGH Decline Charts

-
Sermorelin Products

-
Sermorelin Health









